Tariffs Cast a Shadow on Abbott's 2025 View: Time to Sell ABT Stock?

Abbott Laboratories ABT has recorded a 15% rise in its share price year to date. Despite the company reporting a solid first-quarter 2025 earnings beat last week, external pressure, particularly the ongoing tariff war, has dampened investors' enthusiasm and capped further market gains. Let's delve deeper.Since its earnings release on...